hepatocellular carcinoma Genetron Health, Wuxi Government Form Joint Venture for Liver Cancer Screening Test The company's HCCscreen assay will be used in a liver cancer screening public health initiative, generating real-world data on the test's clinical validity and impact. Ymir Genomics Licenses Urine Biomarkers for Liver Disease Detection From OHSU Ymir Genomics and OHSU will share in any value created by the biomarkers and will jointly publish and validate the biomarkers in a large-scale multi-center study. 'Jaggedness' of Cell-Free DNA Ends Correlates With Fetal, Tumor Origin, Study Finds Premium The method, called jagged end analysis by sequencing and developed by a team in Hong Kong, relies on DNA end repair with methylated or unmethylated cytosine. Exact Sciences Marker Panel Detects Early Liver Cancer With Triple Sensitivity of Current Biomarker Premium The company released data showing that its panel detects early-stage liver cancer with 71 percent sensitivity compared to 25 percent for the standard test. Fluxion Biosciences, Cleveland Clinic Validating Erase-Seq Mutation Variant Caller Platform Premium The firm is partnering with the Cleveland Clinic to validate its mutation variant caller platform in hepatocellular cancer cell-free tumor DNA samples. Mar 13, 2019 Genetron Health Adds Prospective Data on Early Detection of Viral Liver Cancer in Blood Premium Dec 27, 2018 Epigenomics Pushes New Promotion Efforts for ProColon Test as Other Assays in Pipeline Advance Premium Nov 15, 2018 Laboratory for Advanced Medicine Shares New Data on IvyGene Test Performance in Liver Cancer Premium Sep 27, 2018 JBS Science Awarded $3M To Commercialize Liver Cancer Screening Test Nov 14, 2017 Ymir Genomics, OHSU Knight Cancer Institute Collaborate to Develop HCC Biomarkers Oct 18, 2017 Liver Cancer Genomes Reveal Extent of Exposure to Mutagenic Herbal Remedy Compounds Jan 26, 2017 Circulating Tumor Cell Strategy Could Improve Liver Cancer Screening Premium Mar 30, 2015 Exome Sequencing of Hepatocellular Carcinomas Reveals Disease Signature, Potential Treatment Targets Nov 20, 2014 Mirna Releases Phase I Data Showing Manageable Safety Profile for microRNA Rx Premium Nov 6, 2014 Genomics in the Journals Nov 6, 2014 Apr 9, 2014 At AACR, Researchers Highlight Multiple Roles of microRNAs in Cancer Apr 26, 2013 Trovagene, PerkinElmer Ink Assay Development Deal Targeting Liver Cancer Apr 17, 2013 NanoString Takes Option to Liver Cancer Gene Signature for Possible Assay Development Jan 31, 2013 PhaseRx Inks Tech-Evaluation Deal with Monsanto as It Advances Liver Cancer Program Premium Nov 24, 2010 IntegraGen Licenses Biomarkers to Develop Dx for Liver Cancer Sep 7, 2010 Q&A: Pfizer's Mao Mao on Using Next-Generation Sequencing in Drug Development Premium Jul 21, 2010 Pfizer/Samsung Collaboration to Focus on PGx Strategies to Personalize Liver Cancer Treatments in Korea Premium Apr 23, 2009 RNAi Grant Roundup Premium Apr 9, 2009 Alnylam Starts Phase I Study of siRNA Liver Cancer Drug Premium Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.